These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 2654919)

  • 21. [The role of the system of hemostasis in the development of vascular lesions in diabetes mellitus].
    Lapotnikov VA; Moiseev SI
    Ter Arkh; 1988; 60(9):31-5. PubMed ID: 3217876
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Modification of hemorheological parameters in microvascular complications of diabetes].
    Bauduceau B; Renaudeau C; Mayaudon H; Hélie C; Ducorps M; Sonnet E; Yvert JP
    Diabete Metab; 1995 Jun; 21(3):188-93. PubMed ID: 7556810
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of advanced glycation end product (AGE)-induced receptor (RAGE) expression in diabetic vascular complications.
    Chawla D; Bansal S; Banerjee BD; Madhu SV; Kalra OP; Tripathi AK
    Microvasc Res; 2014 Sep; 95():1-6. PubMed ID: 24984291
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Evaluation of various hemorheologic parameters in diabetes mellitus].
    Cella A; Bianchi E; Reali GL; Piana A; Armani U
    Boll Soc Ital Biol Sper; 1990 Apr; 66(4):335-42. PubMed ID: 2390223
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Role of endothelin I and angiotensin II in type 2 diabetics with coronary disease].
    Mundo-Sagardía J; Altieri P; Banch H; González R; Escobales N; Crespo M; Rodríguez-Orengo J; Cardona F; Torrado J
    Bol Asoc Med P R; 2003; 95(5):45-50. PubMed ID: 15008361
    [No Abstract]   [Full Text] [Related]  

  • 26. Serum Levels of Progranulin Are Closely Associated with Microvascular Complication in Type 2 Diabetes.
    Xu L; Zhou B; Li H; Liu J; Du J; Zang W; Wu S; Sun H
    Dis Markers; 2015; 2015():357279. PubMed ID: 26106251
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Serum levels of endothelial monocyte-activating polypeptide-II in type 2 diabetes mellitus].
    Mohyl'nyts'ka LA
    Fiziol Zh (1994); 2014; 60(1):84-90. PubMed ID: 24809179
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Possibility of early diagnosis of diabetic nephropathies].
    Tornóczky J; Hoffmann E; Sziládi E; Pasztarak E; Vastag O; Kottmayer K
    Orv Hetil; 1989 Feb; 130(9):439-44. PubMed ID: 2648249
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Plasma, erythrocyte and platelet magnesium in essential hyperTension, diabetes mellitus without and with macrovascular complications and atherosclerotic vascular disease].
    Grifò G; Lo Presti R; Montana M; Canino B; Caimi G
    Recenti Prog Med; 1995 Nov; 86(11):431-6. PubMed ID: 8539474
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Significance of increased endothelin level for development of sequelae of diabetes mellitus].
    Haak T; Jungmann E; Hillmann U; Felber A; Usadel KH
    Med Klin (Munich); 1993 May; 88(5):291-6. PubMed ID: 8326915
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiovascular complications of diabetes.
    Lau DC; Shen GX
    Can J Diabetes; 2013 Oct; 37(5):279-81. PubMed ID: 24500552
    [No Abstract]   [Full Text] [Related]  

  • 32. [Hemostasis and lipid metabolism in patients with non-insulin- dependent diabetes mellitus and angiopathy of the lower extremities].
    Mamedgasanov RM; Semavin IE; Smirnova LM; Rudenko GR; Riazanov IuI
    Klin Med (Mosk); 1989 Aug; 67(8):74-6. PubMed ID: 2811244
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Significance of high-density lipoprotein cholesterol in the development of ischemic heart disease in diabetes mellitus patients].
    Bodnar PN; Donish RM; Panasiukova OR
    Probl Endokrinol (Mosk); 1984; 30(3):19-24. PubMed ID: 6739447
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased binding of beta-2-microglobulin to blood cells in dialysis patients treated with high-flux dialyzers compared with low-flux membranes contributed to reduced beta-2-microglobulin concentrations. Results of a cross-over study.
    Traut M; Haufe CC; Eismann U; Deppisch RM; Stein G; Wolf G
    Blood Purif; 2007; 25(5-6):432-40. PubMed ID: 17957097
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Changes of plasma total homocysteine in type I diabetic patients its association with diabetic vascular complications].
    Yu TT; Ran XW
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Nov; 39(6):980-4. PubMed ID: 19253841
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Serum level of sL-selectin and leukocyte surface expression of L-selectin in patients with type 2 diabetes].
    Mastej K; Adamiec R
    Przegl Lek; 2011; 68(3):140-5. PubMed ID: 21812228
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A crosstalk between macroangiopathy and microangiopathy in type 2 diabetes.
    Hamasaki H; Moriyama S; Yanai H
    Int J Cardiol; 2013 Sep; 168(1):550-1. PubMed ID: 23453875
    [No Abstract]   [Full Text] [Related]  

  • 38. Relationship between erythrocyte sorbitol content and diabetic microangiopathy in patients with non-insulin-dependent diabetes mellitus: the study of a diet loading test.
    Hasegawa G; Tsutsumi Y; Aoki S; Sawada M; Setoguchi J; Nakamura N; Nakano K; Kondo M; Kanatsuna T
    Diabetes Res Clin Pract; 1991 Jul; 12(3):143-8. PubMed ID: 1889344
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vitamin C metabolites and microangiopathy in diabetes mellitus.
    Jennings PE; Chirico S; Jones AF; Lunec J; Barnett AH
    Diabetes Res; 1987 Nov; 6(3):151-4. PubMed ID: 3436115
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Coagulation profile in diabetes and its association with diabetic microvascular complications.
    Madan R; Gupt B; Saluja S; Kansra UC; Tripathi BK; Guliani BP
    J Assoc Physicians India; 2010 Aug; 58():481-4. PubMed ID: 21189694
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.